First COVID-19 vaccine tested in America ready for final testing

Vaccines for the novel coronavirus are being tested around the world. Now the results of these vaccines are also coming to the fore. Now Moderna Inc. has been added to the chain. Tests on the first two stages of COVID-19 (CoronaVirus) first tested in the United States.

The vaccine is now being tested for the last time. Most importantly, one of the things that emerged from Tuesday's report was that the vaccine worked on people's immune systems in exactly the same way that scientists had hoped.

Speaking to the Associated Press, Dr. Anthony Fossey, a senior infectious disease specialist at the U.S. government, said: "This is very good news. The experimental vaccine is being developed jointly by the National Institutes of Health and Modern Inc. The most essential and last of these vaccines.

The vaccine was first tested on 45 people in March. All the researchers were eagerly awaiting the results of this test. The vaccine, which was released on Tuesday, is expected to boost immunity.

A team of scientists told the New England Journal of Medicine that the volunteers tested developed neutralizing antibodies that stopped the infection.

Lisa Jackson, a doctor at the Washington Research Institute for Permanent Cancer in Seattle, who led the research, said: As a result, the vaccine can protect humans from infection.

It is unknown at this time what he will do after leaving the post. However, the government hopes that the vaccine results will be available by the end of this year. Attempts are being made to develop this vaccine very fast. Two doses of this vaccine will be given.

Research has not shown any serious side effects of this vaccine. But, more than half of the people involved in the research have reported flu-like symptoms.

However, few complaints usually appear after a dose of all types of vaccines. Fatigue, headaches, chills, fever or pain at the injection site are common.

William Schaffner, a doctor at Vanderbilt University Medical Center, said the initial results of the vaccine were a good step and promising. Also, is this vaccine really safe and effective to make available until next year? This is the final stage.